FDA Clears First Non-drug Prescription Device for Women with Osteopenia: Company representatives talk about differentiating the device’s design and navigating FDA’s Breakthrough Device designation
At a Glance –
• The device uses vibration technology to promote bone health.
• Clinical trials validate the device’s effectiveness in reducing bone strength loss and vertebral bone density.
• The company is in discussions with payers/insurers regarding pricing and coverage.